Radioactive bandage zaps skin cancer in early trial
NCT ID NCT04480645
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early pilot study tested a new radioactive bandage called CivaDerm on 10 people with common skin cancers (basal cell or squamous cell carcinoma). The bandage delivers radiation directly to the skin surface, aiming to destroy cancer cells while sparing healthy tissue. The study checked for skin side effects and how much radiation reached the tumor.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radioactive bandage (palladium-103)
- What this could lead to
- If it works, this could offer a simpler, targeted radiation treatment for common skin cancers without surgery.
- What could go wrong
- This is a very early pilot study with only 10 people. It is not yet proven to be safe or effective, and radiation can cause skin reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CivaDerm Oncology PLLC
Morrisville, North Carolina, 27560, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New skin patch could speed recovery after skin cancer removal
- AI reads skin lesions to predict cancer aggressiveness
- Needle-Free light therapy shows promise for common skin cancer
- New radiation implant shows promise for skin cancer